• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    EMEA Blood Glucose Monitoring Market Share

    ID: MRFR/MED/0164-HCR
    115 Pages
    Rahul Gotadki
    October 2025

    Europe, Middle East, and Africa Blood Glucose Monitoring Market Research Report Information, By Product Types (Invasive Glucose Monitoring, CGM, Flash Glucose Monitoring), Applications (Type 1 Diabetes, Type 2 Diabetes), and End Users (Diagnostic Centers, Hospitals, Clinics) - Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    ReportInfographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Share

    EMEA Blood Glucose Monitoring Market Share Analysis

    The Blood Glucose Monitoring market is fiercely competitive, and companies employ various positioning strategies to secure and enhance their market share. One prevalent approach is differentiation, where companies strive to distinguish their products from competitors through unique features or technology. For instance, some companies invest heavily in research and development to introduce innovative features, such as continuous glucose monitoring or user-friendly interfaces. By offering something distinct, they aim to attract customers who prioritize specific functionalities.

    Another strategy is cost leadership, where companies focus on producing blood glucose monitoring devices at a lower cost than their rivals. This can be achieved through economies of scale, efficient production processes, or strategic partnerships with suppliers. The goal is to capture a larger market share by offering affordable options without compromising quality. This strategy is particularly effective in markets where price sensitivity is a significant factor influencing purchasing decisions.

    Market segmentation is also a key strategy in the blood glucose monitoring industry. Companies tailor their products to specific customer segments based on factors such as age, lifestyle, or medical conditions. For example, some companies develop devices that cater specifically to children or seniors, considering their unique needs and preferences. By understanding the diverse requirements of their target audience, companies can better position their products and capture a larger share of niche markets.

    Brand positioning plays a crucial role in influencing consumer perceptions. Companies often invest in building a strong brand image, associating their products with reliability, accuracy, and user-friendliness. A positive brand reputation can significantly impact customer loyalty and attract new users. Effective marketing campaigns, testimonials, and partnerships with healthcare professionals are common tactics to reinforce a brand's position in the market.

    In addition to product-related strategies, companies also focus on distribution channels to enhance their market share. Establishing partnerships with healthcare providers, pharmacies, and online platforms can improve accessibility and reach a broader customer base. Ensuring a strong presence in both traditional and digital channels enables companies to meet the diverse preferences of their target audience.

    Furthermore, strategic alliances and collaborations are employed to strengthen market positioning. Companies may enter partnerships with healthcare institutions, research organizations, or technology companies to leverage expertise, access new markets, or co-develop innovative solutions. These collaborations not only enhance the credibility of the involved companies but also contribute to a more comprehensive and integrated approach to blood glucose monitoring.

    The regulatory landscape is another critical aspect influencing market share positioning. Companies that demonstrate compliance with regulatory standards and gain necessary certifications can build trust among customers and healthcare professionals. This trust is invaluable in a market where accuracy and reliability are paramount.

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the size of EMEA Blood Glucose Monitoring industry in 2024

    EMEA Blood Glucose Monitoring industry is projected to grow from USD 8.03 Billion in 2024

    Market Summary

    Market Trends

    EMEA Blood Glucose Monitoring Market Market Drivers

    Market Segment Insights

    EMEA Blood Glucose Monitoring Product Type Insights

    On the basis of the product type, the EMEA blood glucose monitoring market is segmented into invasive glucose monitoring devices, continuous glucose monitoring devices (CGM), flash glucose monitoring devices, and others.

    Europe, the Middle East, and Africa Blood Glucose Monitoring Application Insights

    On the basis of the application, EMEA blood glucose monitoring market is segmented into type 1 diabetes, type 2 diabetes, and others.

    EMEA Blood Glucose Monitoring End User Insights

    On the basis of the end user, EMEA blood glucose monitoring market is segmented into diagnostic centers, hospitals, clinics, research centers, and home care diagnostics.

    Regional Insights

    Industry Developments

    Market Segmentation

    Report Scope

    Attribute/Metric Details
    Market Size 2023 7.62 (USD Billion)
    Market Size 2024 8.03 (USD Billion)
    Market Size 2032 14.2 (USD Billion)
    Compound Annual Growth Rate (CAGR) 10.99 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
    Geographies Covered Europe, Middle East, and Africa
    Key Vendors Abbott Laboratories (US), Arkay Inc. (Japan), Bayer Healthcare AG, (Germany), F.Hoffmann-La Roche (Switzerland), LifeScan, Johnson & Johnson (U.S.), Medtronic plc., Nipro Diagnostics Inc., and Terumo Medical Corporation

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    What is the size of EMEA Blood Glucose Monitoring industry in 2024

    EMEA Blood Glucose Monitoring industry is projected to grow from USD 8.03 Billion in 2024

    1. Report Prologue
    2. Market Introduction
      1. Definition
      2. Scope of the Study
        1. Research Objective
        2. Assumptions
        3. Limitations
    3. Research Methodology
      1. Introduction
      2. Primary Research
      3. Secondary research
      4. 3.4
      5. Market Size Estimation
    4. Market Dynamics
      1. Drivers
      2. Restrains
      3. Opportunities
      4. Challenges
      5. Macroeconomic Indicators
      6. 4.6
      7. Technology Trends & Assessment
    5. Market Factor Analysis
      1. Porters
        1. Bargaining Power of Suppliers
        2. Bargaining
        3. Threat of New Entrants
        4. Threat of Substitutes
        5. Intensity of Rivalry
      2. Five Forces Analysis
      3. Power of Buyers
      4. Value Chain Analysis
      5. Investment
      6. Feasibility Analysis
      7. Pricing Analysis
    6. EMEA Blood Glucose Monitoring
    7. Market, by Product Type
      1. Introduction
      2. Invasive Glucose Monitoring
        1. Market Estimates & Forecast, 2020-2027
      3. Devices
      4. Continuous
        1. Market Estimates & Forecast, 2020-2027
      5. Glucose Monitoring Devices
      6. Flash Glucose Monitoring Devices
        1. Market Estimates & Forecast,
      7. Others
    8. EMEA Blood Glucose Monitoring Market, by Application
      1. Introduction
      2. Type 1 Diabetes
        1. Market Estimates & Forecast,
      3. Type 2 Diabetes
        1. Market Estimates & Forecast, 2020-2027
      4. Others
        1. Market Estimates & Forecast, 2020-2027
    9. EMEA
    10. Blood Glucose Monitoring Market, by End User
      1. Introduction
      2. Hospitals
        1. Market Estimates & Forecast, 2020-2027
      3. Diagnostic Centers
        1. Market Estimates & Forecast, 2020-2027
      4. Clinics
        1. Market
      5. Estimates & Forecast, 2020-2027
      6. Research centers
        1. Market
      7. Estimates & Forecast, 2020-2027
      8. Homecare Diagnostics
        1. Market
      9. Estimates & Forecast, 2020-2027
    11. EMEA Blood Glucose Monitoring Market,
      1. by Region
      2. Introduction
      3. Europe
        1. Western Europe
        2. France
        3. U.K.
        4. Italy
        5. Spain
        6. Eastern Europe
      4. 9.2.1
      5. Germany
      6. 9.2.6
      7. Rest of Western Europe
      8. The Middle East &
        1. United Arab Emirates
        2. Saudi Arabia
        3. Oman
        4. Kuwait
        5. Qatar
        6. Rest of the Middle East & Africa
      9. Africa
    12. Company Landscape
      1. Introduction
      2. Market Share Analysis
      3. Key Development & Strategies
        1. Key Developments
      4. 11
      5. Company Profiles
      6. Abbott Laboratories
        1. Company Overview
        2. Product Overview
        3. Financials
        4. SWOT Analysis
      7. Arkay, Inc.
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
      8. Bayer Healthcare AG
        1. Company Overview
        2. Product
        3. Financial Overview
        4. Key Development
      9. Overview
      10. 11.3.5
      11. SWOT Analysis
      12. F. Hoffmann-La Roche
        1. Company Overview
        2. Financial Overview
        3. Key
        4. SWOT Analysis
      13. 11.4.2
      14. Product/Business Segment Overview
      15. Development
      16. LifeScan
        1. Company Overview
        2. Product Overview
        3. Financial overview
        4. Key Developments
    13. MRFR Conclusion
      1. Key Findings
        1. From CEO’s View
        2. Unmet Needs of the Market
      2. Point
      3. Key Companies to Watch
      4. Prediction of Pharmaceutical Industry
    14. Appendix
    15. LIST OF TABLES
    16. Blood glucose monitoring Industry Synopsis,
    17. EMEA Blood glucose monitoring Market Estimates and Forecast,
    18. EMEA Blood glucose monitoring Market by Country,
    19. EMEA Blood glucose monitoring Market by Product
      1. Type, 2020-2027, (USD Million)
    20. EMEA Blood glucose monitoring Market
      1. by Application, 2020-2027, (USD Million)
    21. EMEA Blood glucose monitoring
      1. Market by End User, 2020-2027, (USD Million)
    22. Germany Blood glucose
      1. monitoring Market by Types, 2020-2027, (USD Million)
    23. Germany Blood
      1. glucose monitoring Market by Application, 2020-2027, (USD Million)
      2. Table 9
      3. Germany Blood glucose monitoring Market by End User, 2020-2027, (USD Million)
    24. France Blood glucose monitoring Market by Types, 2020-2027, (USD Million)
    25. France Blood glucose monitoring Market by Application, 2020-2027, (USD
      1. Million)
    26. France Blood glucose monitoring Market by End User, 2020-2027,
      1. (USD Million)
    27. United Kingdom Blood glucose monitoring Market by Types,
    28. United Kingdom Blood glucose monitoring Market
      1. by Application, 2020-2027, (USD Million)
    29. United Kingdom Blood glucose
      1. monitoring Market by End User, 2020-2027, (USD Million)
    30. Italy Blood
      1. glucose monitoring Market by Types, 2020-2027, (USD Million)
    31. Italy
      1. Blood glucose monitoring Market by Application, 2020-2027, (USD Million)
      2. Table
    32. Italy Blood glucose monitoring Market by End User, 2020-2027, (USD Million)
    33. Spain Blood glucose monitoring Market by Types, 2020-2027, (USD Million)
    34. Spain Blood glucose monitoring Market by Application, 2020-2027, (USD
      1. Million)
    35. Spain Blood glucose monitoring Market by End User, 2020-2027,
      1. (USD Million)
    36. Rest of Western Europe Blood glucose monitoring Market
      1. by Types, 2020-2027, (USD Million)
    37. Rest of Western Europe Blood glucose
      1. monitoring Market by Application, 2020-2027, (USD Million)
    38. Rest of
      1. Western Europe Blood glucose monitoring Market by End User, 2020-2027, (USD Million)
    39. United Arab Emirates Blood glucose monitoring Market by Types, 2020-2027,
      1. (USD Million)
    40. United Arab Emirates Blood glucose monitoring Market
      1. by Application, 2020-2027, (USD Million)
    41. United Arab Emirates Blood
      1. glucose monitoring Market by End User, 2020-2027, (USD Million)
    42. Saudi
      1. Arabia Blood glucose monitoring Market by Types, 2020-2027, (USD Million)
      2. Table
    43. Saudi Arabia Blood glucose monitoring Market by Application, 2020-2027, (USD
      1. Million)
    44. Saudi Arabia Blood glucose monitoring Market by End User,
    45. Oman Blood glucose monitoring Market by Types,
    46. Oman Blood glucose monitoring Market by Application,
    47. Oman Blood glucose monitoring Market by End
      1. User, 2020-2027, (USD Million)
    48. Kuwait Blood glucose monitoring Market
      1. by Types, 2020-2027, (USD Million)
    49. Kuwait Blood glucose monitoring
      1. Market by Application, 2020-2027, (USD Million)
    50. Kuwait Blood glucose
      1. monitoring Market by End User, 2020-2027, (USD Million)
    51. Qatar Blood
      1. glucose monitoring Market by Types, 2020-2027, (USD Million)
    52. Qatar
      1. Blood glucose monitoring Market by Application, 2020-2027, (USD Million)
      2. Table
    53. Qatar Blood glucose monitoring Market by End User, 2020-2027, (USD Million)
    54. Rest of the Middle East & Africa Blood glucose monitoring Market
      1. by Types, 2020-2027, (USD Million)
    55. Rest of the Middle East & Africa
      1. Blood glucose monitoring Market by Application, 2020-2027, (USD Million)
      2. Table
    56. Rest of the Middle East & Africa Blood glucose monitoring Market by End User,
    57. LIST OF FIGURES
    58. Research
      1. Process
    59. Segmentation for EMEA Blood Glucose Monitoring Market
      1. Figure
    60. Segmentation Market Dynamics for Blood Glucose Monitoring Market
      1. Figure 4
    61. EMEA Blood Glucose Monitoring Market Share, by Product Type 2020
    62. EMEA
    63. Blood Glucose Monitoring Market Share, by Application 2020
    64. EMEA Blood
    65. Glucose Monitoring Market Share, by End User, 2020
    66. EMEA Blood Glucose
    67. Monitoring Market Share, by Country, 2020
    68. EMEA Blood Glucose Monitoring
      1. Market: Company Share Analysis, 2020 (%)
    69. Abbott Laboratories.: Key
      1. Financials
    70. Abbott Laboratories.: Segmental Revenue
      1. Figure 11
      2. Abbott Laboratories.: Geographical Revenue
    71. Arkay, Inc.: Key Financials
    72. Arkay, Inc.: Segmental Revenue
    73. Arkay, Inc.: Geographical
      1. Revenue
    74. Bayer Healthcare AG: Key Financials
    75. Bayer
      1. Healthcare AG: Segmental Revenue
    76. Bayer Healthcare AG: Geographical
      1. Revenue
    77. F. Hoffmann-La Roche: Key Financials
    78. F. Hoffmann-La
      1. Roche: Segmental Revenue
    79. F. Hoffmann-La Roche: Geographical Revenue
    80. LifeScan Diagnostics Inc.: Key Financials
    81. LifeScan Diagnostics
      1. Inc.: Segmental Revenue
    82. LifeScan Diagnostics Inc.: Geographical Revenue

    Europe, Middle East, and Africa Blood Glucose Monitoring Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials